Baxter International | BAX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 491.69M 242K 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Fresenius EUR 19.77B 1.14B 2025-12
Globus Medical USD 4.73B 159.06M 2026-03
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
ICU Medical USD 2.11B 11.9M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03